Topline data were announced from a phase 3 trial investigating lorundrostat for the treatment of uncontrolled hypertension or resistant hypertension.

(HealthDay News) — Stopping glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment 14 days before total joint arthroplasty can minimize risks for complications, according to a study presented ...

Sexual function data support enzalutamide use in men with high-risk biochemically recurrent (BCR) prostate cancer.

Real-world data support clinical trial results showing less gastrointestinal toxicity with use of a rectal spacer during prostate cancer radiation therapy.

(HealthDay News) — In a clinical practice guideline issued by the American Society for Radiation Oncology and published online in Practical Radiation Oncology, evidence-based recommendations are ...

Up to 30% of acute kidney injury (AKI) survivors requiring dialysis and personalized care after discharge from the hospital.

(HealthDay News) — For patients with distant-stage cancers, there was an increase in early palliative care (PC) billing from 2010 to 2019, but the level remained low, according to a study published ...

US cancer patients have reported positive and negative experiences when sharing patient-identified information with their health care providers.

A significant percentage of patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) demonstrate coronary artery calcification (CAC) on imaging, with variations by ANCA ...

(HealthDay News) — Exercise, particularly strengthening exercise and aerobic exercise, can improve the sleep quality of older adults, according to a review published online in Family Medicine and ...

Kidney function declined significantly more in the nephrolithiasis group over approximately 3 years: -16.53 vs -12.82 mL/min/1.73 m², the investigators reported. Nephrolithiasis was independently ...

Certain metabolic factors are associated with the development of chronic musculoskeletal pain, including higher BMI and the presence of diabetes.